SSX5 anticorps (Middle Region)

N° du produit ABIN2774973

Cet anticorps anti-SSX5 est un anticorps Lapin Polyclonal détectant SSX5 dans WB. Adapté pour Humain.

Aperçu rapide pour SSX5 anticorps (Middle Region) (ABIN2774973)

Antigène: SSX5 (Synovial Sarcoma, X Breakpoint 5 (SSX5))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp SSX5 est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-SSX5 anticorps

Épitope: Middle Region

Séquence: GRLQGIFPKI TPEKPAEEGN DSKGVPEASG PQNNGKQLRP SGKLNTSEKV

Homologie: Human: 100%

Attributs du produit: This is a rabbit polyclonal antibody against SSX5. It was validated on Western Blot using a cell lysate as a positive control.

Purification: Affinity Purified

Immunogène: The immunogen is a synthetic peptide directed towards the middle region of human SSX5

Information d'application

Indications d'application: Optimal working dilutions should be determined experimentally by the investigator.

Commentaires:

Antigen size: 229 AA

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freeze-thaw cycles.

Stock: -20 °C

Stockage commentaire: For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.

Détails sur SSX5

Antigène: SSX5 (Synovial Sarcoma, X Breakpoint 5 (SSX5))

Autre désignation: SSX5

Sujet: SSX5 belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. The gene encoding SSX5 appears not to be involved in this type of chromosome translocation. The product of this gene belongs to the family of highly homologous synovial sarcoma X (SSX) breakpoint proteins. These proteins may function as transcriptional repressors. They are also capable of eliciting spontaneously humoral and cellular immune responses in cancer patients, and are potentially useful targets in cancer vaccine-based immunotherapy. SSX1, SSX2 and SSX4 genes have been involved in the t(X,18) translocation characteristically found in all synovial sarcomas. This gene appears not to be involved in this type of chromosome translocation. Two transcript variants encoding distinct isoforms have been identified for this gene.
Alias Symbols: MGC9494
Protein Interaction Partner: AGTRAP, ZSCAN1, PCBD2, NFE2,
Protein Size: 229

Poids moléculaire: 26 kDa

ID gène: 6758

NCBI Accession: NM_021015, NP_066295

UniProt: Q5JQ60